Response to: “Beyond Traditional Risk Markers: Is FIB-4 Sufficient in MINOCA?”

Abstract

Get full access to this article

View all access options for this article.

References

Aydın

Demirkıran

Orta

Beyond traditional risk markers: is FIB-4 sufficient in MINOCA?

Angiology. 2026. doi:10.1177/00033197261441898

Küçükukur

Binici

Prognostic value of FIB-4 index and non-alcoholic fatty liver disease in myocardial infarction with non-obstructive coronary arteries: a prospective cohort study. Angiology. 2026. doi:10.1177/00033197261427829

Seo

Polyzos

Park

Mantzoros

CS.

Fibrosis-4 index predicts long-term all-cause, cardiovascular and liver-related mortality in the adult Korean population. Clin Gastroenterol Hepatol. 2023;21(13):3322-3335.

Gorur

Satar

Acehan

Gulen

Nigiz

Sevdımbas

FIB-4, a surrogate marker of liver fibrosis, predicts mortality and adverse events after acute myocardial infarction. Intern Emerg Med. Published online August 19, 2025. doi:10.1007/s11739-025-04094-z

Vieira Barbosa

Milligan

Frick

, et al. Fibrosis-4 index can independently predict major adverse cardiovascular events in nonalcoholic fatty liver disease. Am J Gastroenterol. 2022;117(3):453-461.

Stahl

Dhindsa

Lee

Sandesara

Chalasani

Sperling

LS.

Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(8):948-963.

Milzi

Dettori

Lubberich

, et al. Coronary microvascular dysfunction is a hallmark of all subtypes of MINOCA. Clin Res Cardiol. 2024;113:1622-1628.

Mantovani

Csermely

Petracca

, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(11):903-913.

Zhang

Chen

Zhu

Peng

Jin

Yin

Prognostic value of the FIB-4 index in patients with myocardial infarction with non-obstructive coronary arteries. Int J Cardiol. 2026;445:134045.